Cefprozil Powder, For Suspension
Product Images NDC 68180-273

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cefprozil (NDC 68180-273). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (F2cfb43d 9704 49ca 8eae 97327e62044d 01)

Chemical structure of cefprozil, the active ingredient in CEFPROZIL 250 mg/5mL powder for suspension by Lupin Pharmaceuticals, Inc. The diagram shows the molecular arrangement including key functional groups and bonds typical of this cephalosporin antibiotic.*

FDA Label Image

250ml-50 mL (F2cfb43d 9704 49ca 8eae 97327e62044d 02)

Label for CEFPROZIL 250 mg/5 mL powder for oral suspension by Lupin Pharmaceuticals, Inc. The label includes preparation directions for suspension by adding water to total 41 mL to yield 50 mL suspension, storage instructions, and warnings. The product is manufactured by Lupin Limited, India, and contains 50 mL when mixed. It is for oral use only and prescription use.*

FDA Label Image

250 -75 mL (F2cfb43d 9704 49ca 8eae 97327e62044d 03)

Label for Cefprozil for Oral Suspension USP 250 mg/5 mL powder for suspension by Lupin Pharmaceuticals, Inc. The label states reconstitution instructions to yield 75 mL of oral suspension, dosing information, and storage conditions. It includes NDC 68180-273-02 and manufacturing details.*

FDA Label Image

250-100 mL (F2cfb43d 9704 49ca 8eae 97327e62044d 04)

Label for CEFPROZIL 250 mg/5 mL powder for oral suspension by Lupin Pharmaceuticals, Inc. The 100 mL bottle, when reconstituted, contains cefprozil equivalent to 250 mg per 5 mL with preparation and storage instructions. The label includes directions for use, storage conditions, pharmaceutical handling details, and manufacturing information.*

FDA Label Image

Image (F2cfb43d 9704 49ca 8eae 97327e62044d 132 1)

An illustration showing a bottle with a loose powder and an arrow pointing down towards a liquid, demonstrating how to prepare a suspension by mixing powder with liquid.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.